Peptide Injections: FDA Review, RFK Jr., and Wellness Claims (2026)

The FDA's upcoming review of peptide injections, a trend favored by RFK Jr. and wellness influencers, sparks debate. While supporters tout their benefits, the FDA's career scientists remain skeptical, citing lacking clinical evidence. The meeting, supported by RFK Jr., pits industry advocates against FDA experts, raising questions about conflicts of interest. The outcome may temporarily ease access, but formal approval could take years, leaving consumers in a gray area. This article delves into the complexities, exploring the potential risks and benefits, and the role of industry influence in shaping public health policies.